Published in Neurosci Lett on December 02, 2005
Increased p38 mitogen-activated protein kinase signaling is involved in the oxidative stress associated with oxygen and glucose deprivation in neonatal hippocampal slice cultures. Eur J Neurosci (2011) 0.95
Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals. Dose Response (2007) 0.89
Is vitamin E toxic to neuron cells? Cell Mol Neurobiol (2009) 0.86
Increases in expression of 14-3-3 eta and 14-3-3 zeta transcripts during neuroprotection induced by delta9-tetrahydrocannabinol in AF5 cells. J Neurosci Res (2007) 0.84
The involvement of a P38-like MAP kinase in ABA-induced and H2O2-mediated stomatal closure in Vicia faba L. Plant Cell Rep (2007) 0.84
Evaluation of Δ(9)-tetrahydrocannabinol metabolites and oxidative stress in type 2 diabetic rats. Iran J Basic Med Sci (2016) 0.75
SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett (1995) 9.62
Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol (2002) 6.68
The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol (1998) 5.96
Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem (1997) 2.02
Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron (1995) 1.95
Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem (2002) 1.31
Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and a secondary increase in superoxide production. J Neurosci (2000) 1.29
Oxidative stress-induced apoptosis is mediated by ERK1/2 phosphorylation. Exp Cell Res (2003) 1.22
The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol (2000) 1.17
Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J Neurochem (2001) 1.11
Mechanism of calcium potentiation of oxygen free radical injury to renal mitochondria. A model for post-ischemic and toxic mitochondrial damage. J Biol Chem (1986) 1.10
Exploration of the role of reactive oxygen species in glutamate neurotoxicity in rat hippocampal neurones in culture. J Physiol (2001) 1.05
Regulation of c-Jun N-terminal kinase, p38 kinase and AP-1 DNA binding in cultured brain neurons: roles in glutamate excitotoxicity and lithium neuroprotection. J Neurochem (2003) 1.01
Effect of sesame antioxidants on LPS-induced NO production by BV2 microglial cells. Neuroreport (2003) 1.01
AF5, a CNS cell line immortalized with an N-terminal fragment of SV40 large T: growth, differentiation, genetic stability, and gene expression. Exp Neurol (2002) 1.00
Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: dependence on calcium concentration. Neurosci Lett (1986) 0.98
Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways. Am J Physiol Heart Circ Physiol (2003) 0.94
Neuroprotective effects of the synthetic cannabinoid HU-210 in primary cortical neurons are mediated by phosphatidylinositol 3-kinase/AKT signaling. Mol Cell Neurosci (2005) 0.89
The female sex hormone oestrogen as a neuroprotectant. Trends Pharmacol Sci (1999) 0.89
Involvement of p38 mitogen-activated protein kinase and apoptosis signal-regulating kinase-1 in nitric oxide-induced cell death in PC12 cells. Neurochem Res (2001) 0.86
Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell death. Brain Res Mol Brain Res (2005) 0.86
N-methylated beta-carbolines protect PC12 cells from cytotoxic effect of MPP+ by attenuation of mitochondrial membrane permeability change. Neurosci Res (2003) 0.82
Propofol attenuates lung endothelial injury induced by ischemia-reperfusion and oxidative stress. Anesth Analg (2005) 0.82
[Oxidative stress in bronchopulmonary disease: contribution of N-acetylcysteine (NAC)]. Rev Pneumol Clin (2005) 0.78
Analysis of microarray data using Z score transformation. J Mol Diagn (2003) 6.82
Genomic alterations in cultured human embryonic stem cells. Nat Genet (2005) 3.89
Dopaminergic differentiation of human embryonic stem cells. Stem Cells (2004) 2.30
Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res (2002) 1.76
Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev (2004) 1.75
Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells (2005) 1.58
Assessment of stromal-derived inducing activity in the generation of dopaminergic neurons from human embryonic stem cells. Stem Cells (2008) 1.37
Properties of pluripotent human embryonic stem cells BG01 and BG02. Stem Cells (2004) 1.36
Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation. Stem Cells (2003) 1.30
BG01V: a variant human embryonic stem cell line which exhibits rapid growth after passaging and reliable dopaminergic differentiation. Restor Neurol Neurosci (2004) 1.22
A novel combination of factors, termed SPIE, which promotes dopaminergic neuron differentiation from human embryonic stem cells. PLoS One (2009) 1.11
NTera2: a model system to study dopaminergic differentiation of human embryonic stem cells. Stem Cells Dev (2005) 1.08
A mechanism for the inhibition of neural progenitor cell proliferation by cocaine. PLoS Med (2008) 1.07
Human embryonic stem cells: derivation, culture, and differentiation: a review. Restor Neurol Neurosci (2010) 1.02
Characterization of a new NIH-registered variant human embryonic stem cell line, BG01V: a tool for human embryonic stem cell research. Stem Cells (2005) 1.01
AF5, a CNS cell line immortalized with an N-terminal fragment of SV40 large T: growth, differentiation, genetic stability, and gene expression. Exp Neurol (2002) 1.00
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse. PLoS One (2006) 0.98
An in vitro model of human dopaminergic neurons derived from embryonic stem cells: MPP+ toxicity and GDNF neuroprotection. Neuropsychopharmacology (2006) 0.97
GABAergic lineage differentiation of AF5 neural progenitor cells in vitro. Cell Tissue Res (2006) 0.95
Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease. Brain Res (2007) 0.95
Apoptosis mediated by p53 in rat neural AF5 cells following treatment with hydrogen peroxide and staurosporine. Brain Res (2006) 0.94
Intranigral transplants of immortalized GABAergic cells decrease the expression of kainic acid-induced seizures in the rat. Behav Brain Res (2006) 0.92
Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease. Neurochem Int (2007) 0.90
5-hydroxytryptamine 1A receptor activation protects against N-methyl-D-aspartate-induced apoptotic cell death in striatal and mesencephalic cultures. J Pharmacol Exp Ther (2003) 0.88
Protective effects of Delta(9)-tetrahydrocannabinol against N-methyl-d-aspartate-induced AF5 cell death. Brain Res Mol Brain Res (2005) 0.86
Cocaine causes deficits in radial migration and alters the distribution of glutamate and GABA neurons in the developing rat cerebral cortex. Synapse (2011) 0.85
Increases in expression of 14-3-3 eta and 14-3-3 zeta transcripts during neuroprotection induced by delta9-tetrahydrocannabinol in AF5 cells. J Neurosci Res (2007) 0.84
Gene expression profiling reveals distinct cocaine-responsive genes in human fetal CNS cell types. J Addict Med (2009) 0.84
Dopaminergic neurons derived from BG01V2, a variant of human embryonic stem cell line BG01. Restor Neurol Neurosci (2008) 0.84
Intranigral transplants of a GABAergic cell line produce long-term alleviation of established motor seizures. Behav Brain Res (2008) 0.83
A validated positive chemical ionization GC/MS method for the identification and quantification of amphetamine, opiates, cocaine, and metabolites in human postmortem brain. J Mass Spectrom (2006) 0.82
Delta opioid peptide DADLE and naltrexone cause cell cycle arrest and differentiation in a CNS neural progenitor cell line. Synapse (2010) 0.82
Benefits and risks of intranigral transplantation of GABA-producing cells subsequent to the establishment of kindling-induced seizures. Neurobiol Dis (2008) 0.81
Transcriptional correlates of human substance use. Ann N Y Acad Sci (2008) 0.80
Human embryonic stem cells which express hrGFP in the undifferentiated state and during dopaminergic differentiation. Restor Neurol Neurosci (2009) 0.79
Postmortem diagnosis and toxicological validation of illicit substance use. Addict Biol (2008) 0.79
Truncated N-terminal mutants of SV40 large T antigen as minimal immortalizing agents for CNS cells. Exp Neurol (2005) 0.76
A new technique for modeling neuronal connectivity using human pluripotent stem cells. Restor Neurol Neurosci (2015) 0.76
T155g-immortalized kidney cells produce growth factors and reduce sequelae of cerebral ischemia. Cell Transplant (2002) 0.76
Platelet-derived growth factor-producing cells immortalized from rat mesencephalon with SV40 large T antigen transduced by an AAV vector. Restor Neurol Neurosci (2003) 0.75